arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

CARLSMED, INC.

CARL
$13.81 ▲ +0.13 (+0.99%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
3 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
29
Health
Poor
Bearish
auto_awesome

Analytical Summary

CARLSMED, INC. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $196.4M
Dividend Yield
Revenue Growth 85.9%
Op. Margin -60.5%
ROIC -21.1%
FCF / Share $-2.08
Trailing P/E
Price / Book 3.7x
FCF Yield
Debt / Equity 0.16
info Valuation on last close. End-of-day price, Aug 7, 2026.

3-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$50.51M
↑ +85.9%
Net Income Profit after all expenses
$-29.63M
↓ -22.2%
Operating Margin Operating profit as % of sales
-60.5%
↑ +31.8% 4th
FCF / Share Free cash flow per share
$-2.08
↑ +67.0%
Long-Term Debt Long-term obligations
$15.35M
— -0.4%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
4
Returns
23
Financial Health
50
Cash Quality
65

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 3 years · 10 quarters